Orchid Pharma share news and announcements
NSE: ORCHPHARMABSE: 524372Pharmaceuticals & BiotechnologySmall Cap
Formerly Orchid Chemicals & Pharmaceuticals
Last close ₹823.30down ₹52.25 (5.97%)BSE ₹826.10
Share price at the NSE close on 23 Oct 2026. Previous close ₹875.55.
52-week range of traded prices to 23 Oct 2026
₹480.00Low, 30 Mar 2026₹1,143.50High, 22 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹4,930 Cr919th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 0.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 Aug 2026
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,70,48053.5% delivered
Orchid Pharma analyst meets
23 filed, newest first.
Aug 2026
17 Aug · Analysts
May 2026
19 May · Analysts
Feb 2026
6 Feb · Analysts
Nov 2025
5 Nov · Analysts
Aug 2025
13 Aug · Analysts
7 Aug · Analysts
May 2025
Feb 2025
6 Feb · Analysts
Nov 2024
6 Nov · Analysts
Aug 2024
7 Aug · Analysts
May 2024
17 May · Analysts
Feb 2024
5 Feb · Analysts
Nov 2023
2 Nov · Analysts
May 2023
8 May · Analysts
Feb 2023
14 Feb · Analysts
Dec 2022
Nov 2022
Aug 2022
Feb 2022
15 Feb · Analysts
File name: “ICC”
Dec 2021
20 Dec · Analysts